Cargando…
Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese mid...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522056/ https://www.ncbi.nlm.nih.gov/pubmed/29412381 http://dx.doi.org/10.1590/2359-3997000000305 |
_version_ | 1785110275187277824 |
---|---|
author | Bonfante, Ivan Luiz Padilha Chacon-Mikahil, Mara Patricia Traina Brunelli, Diego Trevisan Gáspari, Arthur Fernandes Duft, Renata Garbellini Oliveira, Alexandre Gabarra Araujo, Tiago Gomes Saad, Mario Jose Abdalla Cavaglieri, Cláudia Regina |
author_facet | Bonfante, Ivan Luiz Padilha Chacon-Mikahil, Mara Patricia Traina Brunelli, Diego Trevisan Gáspari, Arthur Fernandes Duft, Renata Garbellini Oliveira, Alexandre Gabarra Araujo, Tiago Gomes Saad, Mario Jose Abdalla Cavaglieri, Cláudia Regina |
author_sort | Bonfante, Ivan Luiz Padilha |
collection | PubMed |
description | OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese middle-aged men, and also to correlate all variables analyzed with FNDC5/irisin. SUBJECTS AND METHODS: On the basis of a cluster study, middle-aged obese men (IMC: 31.01 ± 1.64 kg/m(2)) were divided into groups of higher and smaller levels of FNDC5/irisin. The levels of leptin, resistin, adiponectin, tumor necrosis factor alpha (TNFα), interleukin 6 and 10 (IL6, IL10), lipopolysaccharide (LPS), glucose, insulin, glycated hemoglobin, insulin resistance and sensibility, lipid profile, risk of T2DM development, body composition, rest energy expenditure, caloric/macronutrient intake and physical fitness were measured. RESULTS: The higher FNDC5/ irisin group presented improved insulin sensibility (homeostasis model assessment - sensibility (HOMA-S) (p = 0.01) and QUICKI index (p < 0.01)), insulin (p = 0.02) and triglyceride levels (p = 0.01), lower insulin resistance (homeostasis model assessment - insulin resistance (HOMA-IR) (p = 0.01), triglycerides/glucose (TYG index) (p = 0.02), neck circumference (p = 0.02), risk of T2DM development (p = 0.02), tendency to decrease serum resistin (p = 0.08) and significant lower LPS levels (p = 0.02). Inverse correlations between FNDC5/irisin and body weight (r −0.46, p = 0.04), neck circumference (r −0.51, p = 0.02), free fat mass (r −0.49, p = 0.02), triglycerides (r −0.43, p = 0.05) and risk of developing T2DM (r −0.61, p = 0.04) were observed. CONCLUSIONS: These results suggest that higher FNDC5/irisin levels in obese middle-aged men are related to a better metabolic profile and lower risk of T2DM development and serum LPS, a potential inducer of insulin resistance. |
format | Online Article Text |
id | pubmed-10522056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-105220562023-09-27 Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk Bonfante, Ivan Luiz Padilha Chacon-Mikahil, Mara Patricia Traina Brunelli, Diego Trevisan Gáspari, Arthur Fernandes Duft, Renata Garbellini Oliveira, Alexandre Gabarra Araujo, Tiago Gomes Saad, Mario Jose Abdalla Cavaglieri, Cláudia Regina Arch Endocrinol Metab Original Article OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese middle-aged men, and also to correlate all variables analyzed with FNDC5/irisin. SUBJECTS AND METHODS: On the basis of a cluster study, middle-aged obese men (IMC: 31.01 ± 1.64 kg/m(2)) were divided into groups of higher and smaller levels of FNDC5/irisin. The levels of leptin, resistin, adiponectin, tumor necrosis factor alpha (TNFα), interleukin 6 and 10 (IL6, IL10), lipopolysaccharide (LPS), glucose, insulin, glycated hemoglobin, insulin resistance and sensibility, lipid profile, risk of T2DM development, body composition, rest energy expenditure, caloric/macronutrient intake and physical fitness were measured. RESULTS: The higher FNDC5/ irisin group presented improved insulin sensibility (homeostasis model assessment - sensibility (HOMA-S) (p = 0.01) and QUICKI index (p < 0.01)), insulin (p = 0.02) and triglyceride levels (p = 0.01), lower insulin resistance (homeostasis model assessment - insulin resistance (HOMA-IR) (p = 0.01), triglycerides/glucose (TYG index) (p = 0.02), neck circumference (p = 0.02), risk of T2DM development (p = 0.02), tendency to decrease serum resistin (p = 0.08) and significant lower LPS levels (p = 0.02). Inverse correlations between FNDC5/irisin and body weight (r −0.46, p = 0.04), neck circumference (r −0.51, p = 0.02), free fat mass (r −0.49, p = 0.02), triglycerides (r −0.43, p = 0.05) and risk of developing T2DM (r −0.61, p = 0.04) were observed. CONCLUSIONS: These results suggest that higher FNDC5/irisin levels in obese middle-aged men are related to a better metabolic profile and lower risk of T2DM development and serum LPS, a potential inducer of insulin resistance. Sociedade Brasileira de Endocrinologia e Metabologia 2017-12-01 /pmc/articles/PMC10522056/ /pubmed/29412381 http://dx.doi.org/10.1590/2359-3997000000305 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Bonfante, Ivan Luiz Padilha Chacon-Mikahil, Mara Patricia Traina Brunelli, Diego Trevisan Gáspari, Arthur Fernandes Duft, Renata Garbellini Oliveira, Alexandre Gabarra Araujo, Tiago Gomes Saad, Mario Jose Abdalla Cavaglieri, Cláudia Regina Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title | Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title_full | Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title_fullStr | Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title_full_unstemmed | Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title_short | Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
title_sort | obese with higher fndc5/irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522056/ https://www.ncbi.nlm.nih.gov/pubmed/29412381 http://dx.doi.org/10.1590/2359-3997000000305 |
work_keys_str_mv | AT bonfanteivanluizpadilha obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT chaconmikahilmarapatriciatraina obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT brunellidiegotrevisan obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT gaspariarthurfernandes obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT duftrenatagarbellini obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT oliveiraalexandregabarra obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT araujotiagogomes obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT saadmariojoseabdalla obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk AT cavagliericlaudiaregina obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk |